03/11/2024 7:24 PM | Krishnan Krish S (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:27 PM | Krishnan Suma (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 3:36 PM | Krishnan Krish S (Reporting) Krystal Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 3:37 PM | Krishnan Suma (Reporting) Krystal Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 7:20 PM | Krystal Biotech (Issuer) ROMANO KATHRYN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 7:09 PM | Krishnan Krish S (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 7:13 PM | Krishnan Suma (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/01/2024 7:16 PM | Krystal Biotech (Issuer) ROMANO KATHRYN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 8:39 PM | Krishnan Suma (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 8:33 PM | Krystal Biotech (Issuer) ROMANO KATHRYN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 8:36 PM | Krishnan Krish S (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2024 12:35 PM | Krystal Biotech (Subject) ROMANO KATHRYN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 6:59 AM | Krystal Biotech (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2024 7:04 AM | Krystal Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/26/2024 6:49 AM | Krystal Biotech (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 8:25 AM | Avoro Capital Advisors LLC (Filed by) Krystal Biotech (Subject)
| Form SC 13G/A | |
01/29/2024 2:26 PM | Krystal Biotech (Subject)
| Form SC 13G/A | |
01/24/2024 4:44 PM | Krystal Biotech (Issuer) Romano Kathryn (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 10:43 AM | Krystal Biotech (Subject) Romano Kathryn (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023 4:17 PM | Krishnan Krish S (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 4:23 PM | Krishnan Suma (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 3:19 PM | Krishnan Krish S (Reporting) Krystal Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023 3:20 PM | Krishnan Suma (Reporting) Krystal Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2023 6:08 AM | Krystal Biotech (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023 6:10 AM | Krystal Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/02/2023 11:07 AM | Krystal Biotech (Subject) ORTH ANDREW C. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2023 4:59 PM | Krishnan Krish S (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2023 5:01 PM | Krishnan Suma (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 3:16 PM | Krishnan Suma (Reporting) Krystal Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2023 3:16 PM | Krishnan Krish S (Reporting) Krystal Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2023 4:30 PM | Krystal Biotech (Subject) ORTH ANDREW C. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2023 3:57 PM | Krystal Biotech (Subject) ORTH ANDREW C. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023 3:56 PM | Krystal Biotech (Subject) ORTH ANDREW C. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/10/2023 5:06 PM | Krystal Biotech (Subject) ORTH ANDREW C. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2023 7:18 AM | Krystal Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2023 6:07 AM | Krystal Biotech (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/07/2023 6:13 AM | Krystal Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/18/2023 3:05 PM | Krystal Biotech (Filer)
| Form S-3ASR | |
07/03/2023 3:35 PM | Krystal Biotech (Issuer) Mazzacco Catherine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 3:20 PM | JANNEY DANIEL (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 3:24 PM | Krystal Biotech (Issuer) Mason Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Trump’s “Tax Free” Retirement Strategy (Ad) Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value.
In other words, a dollar back then would buy $17.82 worth of goods in today's money.
If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… |
07/03/2023 3:27 PM | Krystal Biotech (Issuer) ROSSI DINO A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 3:31 PM | Krystal Biotech (Issuer) Sutherland Everett Rand (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2023 3:16 PM | Gangolli Julian S (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 6:00 PM | Krystal Biotech (Issuer) ORTH ANDREW C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 6:03 PM | JANNEY DANIEL (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 5:21 PM | Krishnan Krish S (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 5:23 PM | Krishnan Suma (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2023 3:23 PM | Krishnan Suma (Reporting) Krystal Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2023 3:35 PM | Krystal Biotech (Subject) Romano Kathryn (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2023 6:32 AM | Krystal Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/11/2023 6:33 AM | Krystal Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/10/2023 8:45 AM | FMR LLC (Filed by) Krystal Biotech (Subject)
| Form SC 13G/A | |
05/08/2023 7:48 AM | Krystal Biotech (Filer)
| Form 424B5 | |
05/08/2023 7:51 AM | Krystal Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2023 7:25 AM | Krystal Biotech (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/08/2023 7:27 AM | Krystal Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/24/2023 6:04 AM | Krystal Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/19/2023 3:19 PM | JANNEY DANIEL (Reporting) Krystal Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2023 3:50 PM | Krishnan Suma (Reporting) Krystal Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2023 3:51 PM | Krishnan Krish S (Reporting) Krystal Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/06/2023 3:43 PM | Krystal Biotech (Filer)
| Form S-3ASR | |
04/04/2023 3:20 PM | Krystal Biotech (Filer)
| Form DEF 14A | |
04/04/2023 3:21 PM | Krystal Biotech (Filer)
| Form DEFA14A | |